Is 2023 the Year for OTC Naloxone?
FDA Law Blog
FEBRUARY 16, 2023
sales of naloxone from a wholesale distributor to a harm reduction program) from certain requirements under the Drug Supply Chain Security Act. Participants were allowed to review the DFL and packaging for an “unlimited” period which is not representative of a high-risk scenario.
Let's personalize your content